These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4019506)

  • 1. Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.
    Olson ST
    J Biol Chem; 1985 Aug; 260(18):10153-60. PubMed ID: 4019506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
    Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
    Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression in a cell-free system of normal and variant forms of human antithrombin III. Ability to bind heparin and react with alpha-thrombin.
    Austin RC; Rachubinski RA; Fernandez-Rachubinski F; Blajchman MA
    Blood; 1990 Oct; 76(8):1521-9. PubMed ID: 2207328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO; Griffith MJ
    Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME
    J Biol Chem; 1983 Dec; 258(23):14708-17. PubMed ID: 6643505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of fractionated heparin in antithrombin-III proteolysis.
    Marciniak E
    Blood; 1982 Mar; 59(3):576-81. PubMed ID: 7037067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin.
    Marciniak E; Gora-Maslak G
    Thromb Res; 1982 Nov; 28(3):411-21. PubMed ID: 7179225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of rat plasma antithrombin III.
    Takahara H; Sinohara H
    Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple complexes of thrombin and heparin.
    Evington JR; Feldman PA; Luscombe M; Holbrook JJ
    Biochim Biophys Acta; 1986 May; 871(1):85-92. PubMed ID: 3697371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
    Patston PA; Schapira M
    Blood; 1994 Aug; 84(4):1164-72. PubMed ID: 8049432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III.
    Griffith MJ; Noyes CM; Church FC
    J Biol Chem; 1985 Feb; 260(4):2218-25. PubMed ID: 3838304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.
    Austin RC; Sheffield WP; Rachubinski RA; Blajchman MA
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):345-51. PubMed ID: 1546950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.